EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Disrupted epithelial permeability as a predictor of severe COVID ‐19 development

Duygu Yazici, Eren Cagan, Ge Tan iD, Manru Li, Evan Do, Ozan C Kucukkase, Abdurrahman Simsek, Muhammed Ali Kizmaz, Tugce Bozkurt, Tamer Aydin, Anja Heider, Beate Rückert und 8 weitere

Allergy · 2023

DOI: 10.1111/all.15800 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Allergy, 2023. Verfasst von Duygu Yazici und 19 weiteren Autor:innen. Beteiligte Einrichtung: Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland. Hauptthemen laut MEDLINE: Proteomics, COVID-19. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Food Allergy Research and Education, National Heart, Lung, and Blood Institute, National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

An impaired epithelial barrier integrity in the gastrointestinal tract is important to the pathogenesis of many inflammatory diseases. Accordingly, we assessed the potential of biomarkers of epithelial barrier dysfunction as predictive of severe COVID‐19.

Methods

Levels of bacterial DNA and zonulin family peptides (ZFP) as markers of bacterial translocation and intestinal permeability and a total of 180 immune and inflammatory proteins were analyzed from the sera of 328 COVID‐19 patients and 49 healthy controls.

Results

Significantly high levels of circulating bacterial DNA were detected in severe COVID‐19 cases. In mild COVID‐19 cases, serum bacterial DNA levels were significantly lower than in healthy controls suggesting epithelial barrier tightness as a predictor of a mild disease course. COVID‐19 patients were characterized by significantly elevated levels of circulating ZFP. We identified 36 proteins as potential early biomarkers of COVID‐19, and six of them (AREG, AXIN1, CLEC4C, CXCL10, CXCL11, and TRANCE) correlated strongly with bacterial translocation and can be used to predict and discriminate severe cases from healthy controls and mild cases (area under the curve (AUC): 1 and 0.88, respectively). Proteomic analysis of the serum of 21 patients with moderate disease at admission which progressed to severe disease revealed 10 proteins associated with disease progression and mortality (AUC: 0.88), including CLEC7A, EIF4EBP1, TRANCE, CXCL10, HGF, KRT19, LAMP3, CKAP4, CXADR, and ITGB6.

Conclusion

Our results demonstrate that biomarkers of intact or defective epithelial barriers are associated with disease severity and can provide early information on the prediction at the time of hospital admission.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProteomicsCOVID-19HumansDNA, BacterialDisease ProgressionBiomarkersPermeabilityMembrane GlycoproteinsReceptors, ImmunologicLectins, C-Type

Stichwörter der Autor:innen

COVID-19bacterial DNAbiomarkerepithelial barrierzonulin family peptides

Substanzen

DNA, BacterialBiomarkersCLEC4C protein, humanMembrane GlycoproteinsReceptors, ImmunologicLectins, C-Type

Autor:innen und Institutionen

  • Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland.
  • Department of Immunology, Bursa Uludag University School of Medicine, Bursa, Turkey.
  • Department of Pediatric Infectious Diseases, Bursa Yuksek Ihtisas Training and Research Hospital, University of Health Sciences, Bursa, Turkey.
  • Sean N. Parker Center for Allergy and Asthma Research, Stanford University School of Medicine, Stanford, California, USA.
  • Christine Kühne-Center for Allergy Research and Education (CK-CARE), Davos, Switzerland.
  • Faculty of Medicine, University of Zurich, Zurich, Switzerland.

ORCID-Profile: Ge Tan, Marie-Charlotte Brüggen, Liam O'Mahony, Mubeccel Akdis, Cezmi A Akdis, Ismail Ogulur

Förderung

  • Food Allergy Research and Education
  • National Heart, Lung, and Blood Institute
  • National Institute of Allergy and Infectious Diseases
  • National Institute of Environmental Health Sciences
  • National Science Foundation
  • Stanford University

Zitieren

APA

Yazici, D., Cagan, E., Tan, G., Li, M., Do, E., Kucukkase, O. C., Simsek, A., Kizmaz, M. A., Bozkurt, T., Aydin, T., Heider, A., Rückert, B., Brüggen, M. C., Dhir, R., O'Mahony, L., Akdis, M., Nadeau, K. C., Budak, F., Akdis, C. A., & Ogulur, I. (2023). Disrupted epithelial permeability as a predictor of severe COVID ‐19 development. Allergy. https://doi.org/10.1111/all.15800

Vancouver

Yazici D, Cagan E, Tan G, Li M, Do E, Kucukkase OC, et al. Disrupted epithelial permeability as a predictor of severe COVID ‐19 development. Allergy. 2023. doi:10.1111/all.15800

BibTeX
@article{Yazici2023,
  author = {Yazici, Duygu and Cagan, Eren and Tan, Ge and Li, Manru and Do, Evan and Kucukkase, Ozan C and Simsek, Abdurrahman and Kizmaz, Muhammed Ali and Bozkurt, Tugce and Aydin, Tamer and Heider, Anja and Rückert, Beate and Brüggen, Marie-Charlotte and Dhir, Raja and O'Mahony, Liam and Akdis, Mubeccel and Nadeau, Kari C and Budak, Ferah and Akdis, Cezmi A and Ogulur, Ismail},
  title = {Disrupted epithelial permeability as a predictor of severe COVID ‐19 development},
  journal = {Allergy},
  year = {2023},
  doi = {10.1111/all.15800}
}
Kostenlos starten →